• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number C146 - KIT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Pain (1994)
Event Date 01/20/2015
Event Type  Injury  
Event Description
During a css training on site, nurse reported that patient, (b)(6) year old girl with acute gvhd in skin and gut, complains about increased abdominal pain on days of ecp treatments.The patient had bone marrow transplant in late (b)(6) and started ecp on (b)(6).Patient is currently treated twice biweekly with blood prime procedures.Patient previously had a reaction to heparin (reported in 2523595-2014-00299/(b)(4)) and is since then treated using acd-a.Nurse stated they doubt the patient really has increased pain after ecp and if so, if it is related to ecp.Nurses stated the treating physician could not see any medical reason for the increased pain.Css has requested additional information regarding other medication and the patient's medical history: temperature 36.5c before, 37.4c after treatment, acd-a was used at a ratio of 10:1, calcium was distributed at 25 ml/h as precaution.The provided treatment information concerns the last patient treatment, on (b)(6) 2015.Weight (b)(6) kg, hct unknown, hgb 5.3 mmol/l, platelets 59 10^9/l; blood pressure 127/82 before, 130/101 after treatment.Temperature 36.5c before, 37.4c after treatment.Acd-a was used at a ratio of 10:1, calcium was distributed at 25 ml/h as precaution.Collect and return rates 10-15 ml/min.1002 ml whole blood processed, of which 276 ml (prime) + 42 ml (buffy coat) from prbc.Treatment volume 129 ml, photoactivation time 4.45 min; kit lot c146.Ecp history: treatment 14.10.14 using heparin and bloodprime.Treatment: patient is bleeding from the gut, protamine is used to neutralize the ani-clotting effects of heparin (from the 2.Series of ecp).From the 5.Treatment: we start using acd-a + infusion of calcium.The patient experiences an increased stomach pain on the days of ecp.Better now than with the heparin, but still worse than other days.Exams of the guts show improvement of the mucous membrane in general, but there is an ulcer of the pyloric channel.There is no sign of bleeding.The patient is on her 12th series of treatment, and is now treated every other week.
 
Manufacturer Narrative
A review of lot c146 was performed and there were no nonconformances associated with this type of failure for this lot.This lot met release requirements.Trends were reviewed for complaint category abdominal pain, and no trend was detected.No capa has been initiated for this complaint category.The assessment is based on information available at the time of the investigation.This case is related to report 2523595-2014-00299/(b)(4), as it is the same patient, same treatment series.Since patient had to receive calcium, therakos is reporting this event for the medical intervention.Kit unique identifier (udi) #: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS, INC.
bridgewater NJ
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 baily ave.
buffalo NY 14211
Manufacturer Contact
10 north high street suite 300
west chester, PA 19380
MDR Report Key4522883
MDR Text Key5410001
Report Number2523595-2015-00040
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
P680003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 01/20/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/01/2016
Device Lot NumberC146 - KIT
Other Device ID Number10705030100009
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/20/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age11 YR
Patient Weight33
-
-